MOVIN' CARE for PD (Mind-body Interventions)

Launched by THE UNIVERSITY OF HONG KONG · Oct 5, 2023

Keywords

ClinConnect Summary

The MOVIN' CARE for PD trial is studying how two mind-body approaches—yoga and arts-based activities—can help improve the overall well-being of people living with Parkinson's Disease (PD). The researchers want to see if these activities can make a real difference in areas such as mental health and social connections, as well as help manage PD symptoms. The study will involve several assessments over nine months to track changes and effects.

To participate, individuals need to be at least 18 years old and diagnosed with mild to advanced Parkinson's Disease. They should be able to walk independently for at least 3 meters and have access to the internet, as the study will likely involve online components. However, those with significant cognitive impairments or who have recently taken part in similar activities or studies may not be eligible. Participants can expect to take part in yoga or arts-based sessions and will have their progress monitored throughout the study to see how well these interventions work.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults who are diagnosed with idiopathic, mild-to-advance PD as indicated by Hoehn and Yahr Scale (19) Stage I to IV (those with unilateral/bilateral symptoms, with/without postural instability who are able to walk at least 3 meters or stand unassisted);
• • aged 18 or above;
• • able to give written informed consent;
• • able to access to the internet and smartphone/ tablet/ laptop will be included; and
• • able to comprehend Chinese will be included.
• Exclusion Criteria:
• • participants have significant cognitive impairment as indicated by the Abbreviated Mental Test lower than 6 significant
• • participants have been regularly engaged in regular instructor-led mind-body exercise (e.g., Taichi) or arts-based therapies (\>2 times per week) in the past 3 months
• • currently participating in any other behavioral or pharmacological trial
• • participants have other contraindication(s) that may limit their full participation (e.g. severe hearing or vision impairment, etc.).